iSAM Funds UK Ltd Purchases 276 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

iSAM Funds UK Ltd boosted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,815 shares of the medical device company’s stock after acquiring an additional 276 shares during the period. iSAM Funds UK Ltd’s holdings in Cooper Companies were worth $443,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Byrne Asset Management LLC bought a new stake in Cooper Companies during the 4th quarter worth approximately $33,000. OFI Invest Asset Management purchased a new position in shares of Cooper Companies in the fourth quarter worth $34,000. New Age Alpha Advisors LLC purchased a new position in shares of Cooper Companies in the fourth quarter worth $38,000. Covestor Ltd lifted its holdings in shares of Cooper Companies by 35.5% in the fourth quarter. Covestor Ltd now owns 458 shares of the medical device company’s stock worth $42,000 after buying an additional 120 shares in the last quarter. Finally, Atala Financial Inc purchased a new position in shares of Cooper Companies in the fourth quarter worth $51,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the topic of several research analyst reports. Robert W. Baird lowered their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. JPMorgan Chase & Co. lowered their target price on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Friday, March 7th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $110.25.

Cooper Companies Price Performance

Cooper Companies stock opened at $81.50 on Wednesday. The company has a market cap of $16.30 billion, a price-to-earnings ratio of 41.80, a PEG ratio of 2.25 and a beta of 1.08. The firm’s fifty day moving average is $80.33 and its 200 day moving average is $89.77. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 52-week low of $69.81 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.